Skip to main content
SpringerLink
Log in

Diabetes Mellitus and Acute Myocardial Infarction: Impact on Short and Long-Term Mortality

  • Chapter
  • First Online:
Diabetes: from Research to Clinical Practice

Part of the book series: Advances in Experimental Medicine and Biology ((AIM,volume 1307))

Abstract

Diabetes mellitus (DM) is an important risk factor for acute myocardial infarction (AMI) and a frequent co-morbidity in patients hospitalized with AMI, being present in about 30% of cases. Although current treatment of AMI has considerably improved survival in both patients with and without DM, the presence of DM still doubles the case fatality rate during both the acute phase of AMI and at long-term follow-up. This higher mortality risk of DM patients strongly indicates a particular need for better treatment options in these patients and suggests that intensive medical treatment, prolonged surveillance, and stringent control of other risk factors should be carefully pursued and maintained for as long as possible in them.

In this review, we will focus on the close association between DM and in-hospital and long-term mortality in AMI patients. We will also aim at providing current evidence on the mechanisms underlying this association and on emerging therapeutic strategies, which may reduce the traditional mortality gap that still differentiates AMI patients with DM from those without.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abbott RD, Donahue RP, Kannel WB, Wilson PW (1988) The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study. JAMA 260:3456–3460

    Article  CAS  PubMed  Google Scholar 

  • Aguilar D, Solomon SD, Køber L, Rouleau JL, Skali H, McMurray JJ et al (2004) Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan in acute myocardial iNfarcTion (VALIANT) trial. Circulation 110:1572–1578

    Article  PubMed  Google Scholar 

  • Ahmed B, Davis HT, Laskey WK (2014) In-hospital mortality among patients with type 2 diabetes mellitus and acute myocardial infarction: results from the national inpatient sample, 2000–2010. J Am Heart Assoc 26:3

    Google Scholar 

  • Alfaleh HF, Alhabib KF, Kashour T, Ullah A, Alsheikhali AA, Al Suwaidi J et al (2014) Short-term and long-term adverse cardiovascular events across the glycaemic spectrum in patients with acute coronary syndrome: the Gulf Registry of Acute Coronary Events-2. Coron Artery Dis 25:330–338

    Article  PubMed  Google Scholar 

  • Arnold SV, Spertus JA, Jones PG et al (2016) Predicting adverse outcomes after myocardial infarction among patients with diabetes mellitus. Circ Cardiovasc Qual Outcomes 9:372–379

    Article  PubMed  PubMed Central  Google Scholar 

  • Avogaro A, Bonora E, Consoli A, Del Prato S, Genovese S, Giorgino F (2019) Glucose-lowering therapy and cardiovascular outcomes in patients with type 2 diabetes mellitus and acute coronary syndrome. Diab Vasc Dis Res 16:399–414

    Article  CAS  PubMed  Google Scholar 

  • Barbash GI, White HD, Modan M, Van de Werf F (1993) Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. J Am Coll Cardiol 22:707–713

    Article  CAS  PubMed  Google Scholar 

  • Bartnik M, Malmberg K, Hamsten A, Efendic S, Norhammar A, Silveira A et al (2004) Abnormal glucose tolerance–a common risk factor in patients with acute myocardial infarction in comparison with population-based controls. J Intern Med 256:288–297

    Article  CAS  PubMed  Google Scholar 

  • Basalay MV, Mastitskaya S, Mrochek A, Ackland GL, Del Arroyo AG, Sanchez J et al (2016) Glucagonlike peptide-1 (GLP-1) mediates cardioprotection by remote ischaemic conditioning. Cardiovasc Res 112:669–676

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Basnet S, Kozikowski A, Makaryus AN, Pekmezaris R, Zeltser R, Akerman M et al (2015) Metformin and myocardial injury in patients with diabetes and ST-segment elevation myocardial infarction: a propensity score matched analysis. J Am Heart Assoc 4:e002314

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Bayrami G, Karimi P, Agha-Hosseini F, Feyzizadeh S, Badalzadeh R (2018) Effect of ischemic postconditioning on myocardial function and infarct size following reperfusion injury in diabetic rats pretreated with vildagliptin. J Cardiovasc Pharmacol Ther 23:174–183

    Article  CAS  PubMed  Google Scholar 

  • Berton G, Citro T, Palmieri R, Petucco S, De Toni R, Palatini P (1997) Albumin excretion rate increases during acute myocardial infarction and strongly predicts early mortality. Circulation 96:3338–3345

    Article  CAS  PubMed  Google Scholar 

  • Berton G, Cordiano R, Palmieri R, De Toni R, Guarnieri GL, Palatini P (2004) Albumin excretion in diabetic patients in the setting of acute myocardial infarction: association with 3-year mortality. Diabetologia 47:1511–1518

    Article  CAS  PubMed  Google Scholar 

  • Berton G, Cordiano R, Mazzuco S, Katz E, De Toni R, Palatini P (2008) Albumin excretion in acute myocardial infarction: a guide for long-term prognosis. Am Heart J 156:760–768

    Article  CAS  PubMed  Google Scholar 

  • Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, CHARISMA Investigators et al (2006) Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 354:1706–1717

    Article  CAS  PubMed  Google Scholar 

  • Bhatt DL, Bonaca MP, Bansilal S, Angiolillo DJ, Cohen M, Storey RF et al (2016) Reduction in ischemic events with Ticagrelor in diabetic patients with prior myocardial infarction in PEGASUS-TIMI 54. J Am Coll Cardiol 67:2732–2740

    Article  CAS  PubMed  Google Scholar 

  • Bohula EA, Giugliano RP, Cannon CP, Zhou J, Murphy SA, White JA et al (2015) Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT. Circulation 132:1224–1233

    Article  CAS  PubMed  Google Scholar 

  • Booth GL, Kapral MK, Fung K, TU JV. (2006) Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet 368:29–36

    Article  PubMed  Google Scholar 

  • Bradley RF, Bryfogle JW (1956) Survival of diabetic patients after myocardial infarction. Am J Med 20:207–216

    Article  CAS  PubMed  Google Scholar 

  • Butler J, Vaduganathan M (2018) Glucose-lowering therapies in patients with concomitant diabetes mellitus and heart failure: finding the “Sweet Spot”. JACC Heart Fail 6:27–29

    Article  PubMed  Google Scholar 

  • Capes SE, Hunt D, Malmberg K, Gerstein HC (2000) Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355:773–778

    Article  CAS  PubMed  Google Scholar 

  • Chen WR, Hu SY, Chen YD, Zhang Y, Qian G, Wang J et al (2015) Effects of liraglutide on left ventricular function in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am Heart J 170:845–854

    Article  CAS  PubMed  Google Scholar 

  • Chow E, Bernjak A, Williams S, Fawdry RA, Hibbert S, Freeman J et al (2014) Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk. Diabetes 63:1738–1747

    Article  CAS  PubMed  Google Scholar 

  • Clark AL, Best CJ, Fisher SJ (2014) Even silent hypoglycemia induces cardiacarrhythmias. Diabetes 63:1457–1459

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Coronado BE, Pope JH, Griffith JL, Beshansky JR, Selker HP (2004) Clinical features, triage, and outcome of patients presenting to the ED with suspected acute coronary syndromes but without pain: a multicenter study. Am J Emerg Med 22:568–574

    Article  PubMed  Google Scholar 

  • Cosentino N, Campodonico J, Faggiano P, De Metrio M, Rubino M, Milazzo V et al (2019a) A new score based on the PEGASUS-TIMI 54 criteria for risk stratification of patients with acute myocardial infarction. Int J Cardiol 278:1–6

    Article  PubMed  Google Scholar 

  • Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V et al (2019b) 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 31:pii: ehz486. (Epub ahead of print)

    Google Scholar 

  • Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T et al (2008) American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 117:1610–1619

    Article  PubMed  Google Scholar 

  • Desouza CV, Bolli GB, Fonseca V (2010) Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care 33:1389–1394

    Article  PubMed  PubMed Central  Google Scholar 

  • Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Taori G et al (2011) The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes. Crit Care Med 39:105–111

    Article  PubMed  Google Scholar 

  • Ertelt K, Brener SJ, Mehran R, Ben-Yehuda O, McAndrew T, Stone GW (2017) Comparison of outcomes and prognosis of patients with versus without newly diagnosed diabetes mellitus after primary percutaneous coronary intervention for ST-elevation myocardial infarction (the HORIZONS-AMI Study). Am J Cardiol 119:1917–1923

    Article  PubMed  Google Scholar 

  • Foo K, Cooper J, Deaner A, Knight C, Suliman A, Ranjadayalan K et al (2003) A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart 89:512–516

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fox KA, Carruthers KF, Dunbar DR, Graham C, Manning JR, De Raedt H et al (2010) Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study). Eur Heart J 31:2755–2764

    Article  PubMed  Google Scholar 

  • Franklin K, Goldberg RJ, Spencer F, Klein W, Budaj A, Brieger D, GRACE investigators et al (2004) Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. Arch Intern Med 164:1457–1463

    Article  PubMed  Google Scholar 

  • Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H (1983) Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. BMJ 287:867–701

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Furtado RHM, Bonaca MP, Raz I, Zelniker TA, Mosenzon O, Cahn A et al (2019) Dapagliflozin and cardiovascular outcomes in patients with type 2 diabetes mellitus and previous myocardial infarction. Circulation 139:2516–2527

    Article  CAS  PubMed  Google Scholar 

  • Geiss LS, Herman WH, Smith PJ (1995) Mortality in non-insulin dependent diabetes. In: Harris M (ed) Diabetes in America, 2nd edn. National Institute of Diabetes and Digestive and Kidney diseases, Bethesda, pp 233–255

    Google Scholar 

  • Gerbaud E, Darier R, Montaudon M, Beauvieux MC, Coffin-Boutreux C, Coste P et al (2019) Glycemic variability is a powerful independent predictive factor of midterm major adverse cardiac events in patients with diabetes with acute coronary syndrome. Diabetes Care 42:674–681

    Article  PubMed  Google Scholar 

  • Giugliano RP, Cannon CP, Blazing MA, Nicolau JC, Corbalán R, Špinar J, IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) Investigators et al (2018) Benefit of adding Ezetimibe to Statin Therapy on Cardiovascular outcomes and safety in patients with versus without diabetes mellitus: results from IMPROVE-IT (Improved reduction of outcomes: Vytorin Efficacy International Trial). Circulation 137:1571–1582

    Article  CAS  PubMed  Google Scholar 

  • Goyal A, Mahaffey KW, Garg J, Nicolau JC, Hochman JS, Weaver WD et al (2006) Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J 27:1289–1297

    Article  CAS  PubMed  Google Scholar 

  • Granger CB, Califf RM, Young S, Candela R, Samaha J, Worley S et al (1993) Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. J Am Coll Cardiol 21:920–925

    Article  CAS  PubMed  Google Scholar 

  • Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D et al (2014) Changes in diabetes-related complications in the United States, 1990–2010. N Engl J Med 370:1514–1523

    Article  CAS  PubMed  Google Scholar 

  • Gunst J, De Bruyn A, Van den Berghe G (2019) Glucose control in the ICU. Curr Opin Anaesthesiol 32:156–162

    Article  PubMed  PubMed Central  Google Scholar 

  • Haffner SM (2000) Coronary heart disease in patients with diabetes. N Engl J Med 342:1040–1042

    Article  CAS  PubMed  Google Scholar 

  • Hay LC, Wilmshurst EG, Fulcher G (2003) Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring. Diabetes Technol Ther 5:19–26

    Article  CAS  PubMed  Google Scholar 

  • Hillis LD, Forman S, Braunwald E, TIMI Phase II Co-investigators (1990) Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. J Am Coll Cardiol 16:313–315

    Article  CAS  PubMed  Google Scholar 

  • Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Nishioka K et al (2003) Impact of acute hyperglycemia on left ventricular function after reperfusion therapy in patients with a first anterior wall acute myocardial infarction. Am Heart J 146:674–678

    Article  CAS  PubMed  Google Scholar 

  • Ishihara M, Kojima S, Sakamoto T, Asada Y, Tei C, Kimura K, Japanese Acute Coronary Syndrome Study Investigators et al (2005) Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era. Am Heart J 150:814–820

    Article  CAS  PubMed  Google Scholar 

  • Iwakura K, Ito H, Ikushima M et al (2003) Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 41:1–7

    Article  CAS  PubMed  Google Scholar 

  • Jaffe AS, Spadaro JJ, Schechtman K, Roberts R, Geltman EM, Sobel BE (1984) Increased congestive heart failure after myocardial infarction of modest extent in diabetes mellitus patients. Am Heart J 108:31–37

    Article  CAS  PubMed  Google Scholar 

  • James S, Angiolillo DJ, Cornel JH, Erlinge D, Husted S, Kontny F et al (2010) Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient outcomes (PLATO) trial. Eur Heart J 31:3006–3016

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jernberg T, Hasvold P, Henriksson M, Hjelm H, Thuresson M, Janzon M (2015) Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective. Eur Heart J 36:1163–1170

    Article  PubMed  Google Scholar 

  • Kadri Z, Danchin N, Vaur L, Cottin Y, Guéret P, Zeller M, USIC 2000 Investigators et al (2006) Major impact of admission glycaemia on 30 day and one year mortality in non-diabetic patients admitted for myocardial infarction: results from the nationwide French USIC 2000 study. Heart 92:910–915

    Article  CAS  PubMed  Google Scholar 

  • Kannel WB, McGee DL (1979) Diabetes and cardiovascular disease. The Framingham study. JAMA 241:2035–2038

    Article  CAS  PubMed  Google Scholar 

  • Kawano H, Motoyama T, Hirashima O, Hirai N, Miyao Y, Sakamoto T et al (1999) Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 34:146–154

    Article  CAS  PubMed  Google Scholar 

  • Kip KE, Faxon DP, Detre KM, Yeh W, Kelsey SF, Currier JW (1996) Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 94:1818–1825

    Article  CAS  PubMed  Google Scholar 

  • Klein HH, Hengstenberg C, Peuckert M, Jurgensen R (1993) Comparison of death rates from acute myocardial infarction in a single hospital in two different periods (1977–1978 versus 1988–1989). Am J Cardiol 71:518–523

    Article  CAS  PubMed  Google Scholar 

  • Kosiborod M (2018) Hyperglycemia in acute coronary syndromes: from mechanisms to prognostic implications. Endocrinol Metab Clin N Am 47:185–202

    Article  Google Scholar 

  • Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP et al (2005) Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 111:3078–3086

    Article  CAS  PubMed  Google Scholar 

  • Kosiborod M, Inzucchi SE, Krumholz HM, Xiao L, Jones PG, Fiske S et al (2008) Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation 117:1018–1027

    Article  CAS  PubMed  Google Scholar 

  • Kosiborod M, Inzucchi SE, Krumholz HM, Masoudi FA, Goyal A, Xiao L et al (2009a) Glucose normalization and outcomes in patients with acute myocardial infarction. Arch Intern Med 169:438–446

    Article  CAS  PubMed  Google Scholar 

  • Kosiborod M, Inzucchi SE, Goyal A, Krumholz HM, Masoudi FA, Xiao L et al (2009b) Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. JAMA 301:1556–1564

    Article  CAS  PubMed  Google Scholar 

  • Krinsley JS, Egi M, Kiss A, Devendra AM, Schuetz P, Maurer P et al (2013) Diabetes status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study. Crit Care 7:R37

    Article  Google Scholar 

  • Lee KL, Woodlief LH, Topol EJ, Weaver WD, Betriu A, Col J et al (1995) Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I investigators. Circulation 91:1659–1668

    Article  CAS  PubMed  Google Scholar 

  • Leibovitz E, Gottlieb S, Goldenberg I, Gevrielov-Yusim N, Matetzky S, Gavish D (2013) Sitagliptin pretreatment in diabetes patients presenting with acute coronary syndrome: results from the Acute Coronary Syndrome Israeli Survey (ACSIS). Cardiovasc Diabetol 12:53

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lønborg J, Vejlstrup N, Kelbæk H, Bøtker HE, Kim WY, Mathiasen AB (2012) Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction. Eur Heart J 33:1491–1499

    Article  PubMed  CAS  Google Scholar 

  • Lønborg J, Vejlstrup N, Kelbæk H, Nepper-Christensen L, Jørgensen E, Helqvist S et al (2014) Impact of acute hyperglycemia on myocardial infarct size, area at risk, and salvage in patients with STEMI and the association with exenatide treatment: results from a randomized study. Diabetes 63:2474–2485

    Article  PubMed  Google Scholar 

  • Malmberg K, Norhammar A, Wedel H, Rydén L (1999) Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 99:2626–2632

    Article  CAS  PubMed  Google Scholar 

  • Marenzi G, De Metrio M, Rubino M, Lauri G, Cavallero A, Assanelli E et al (2010) Acute hyperglycemia and contrast-induced nephropathy in primary percutaneous coronary intervention. Am Heart J 160:1170–1177

    Article  PubMed  Google Scholar 

  • Marenzi G, Cosentino N, Milazzo V, De Metrio M, Cecere M, Mosca S et al (2018a) Prognostic value of the acute-to-chronic glycemic ratio at admission in acute myocardial infarction: a prospective study. Diabetes Care 41:847–853

    Article  CAS  PubMed  Google Scholar 

  • Marenzi G, Cosentino N, Milazzo V, De Metrio M, Rubino M, Campodonico J et al (2018b) Acute kidney injury in diabetic patients with acute myocardial infarction: role of acute and chronic glycemia. J Am Heart Assoc 7(8):pii: e008122

    Article  CAS  Google Scholar 

  • Marenzi G, Cosentino N, Genovese S, Campodonico J, De Metrio M, Rondinelli M et al (2019) Reduced cardio-renal function accounts for most of the in-hospital morbidity and mortality risk among patients with type 2 diabetes undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Diabetes Care 42:1305–1311

    Article  PubMed  Google Scholar 

  • Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, DAPT Study Investigators et al (2014) Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med 371:2155–2166

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Mesotten D, Preiser JC, Kosiborod M (2015) Glucose management in critically ill adults and children. Lancet Diabetes Endocrinol 3:723–733

    Article  CAS  PubMed  Google Scholar 

  • Miettinen H, Lehto S, Salomaa V, Mähönen M, Niemelä M, Haffner SM et al (1998) Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care 21:69–75

    Article  CAS  PubMed  Google Scholar 

  • Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP et al (2006) Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295:1681–1687

    Article  CAS  PubMed  Google Scholar 

  • Mozaffarian D, Marfisi R, Levantesi G, Silletta MG, Tavazzi L, Tognoni G et al (2007) Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors. Lancet 370:667–675

    Article  CAS  PubMed  Google Scholar 

  • Mueller HS, Cohen LS, Braunwald E, Forman S, Feit F, Ross A et al (1992) Predictors of early mortality and morbidity after thrombolytic therapy of acute myocardial infarction: analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II. Circulation 85:1254–1264

    Article  CAS  PubMed  Google Scholar 

  • Murphy JF, Kahn MG, Krone RJ (1995) Prethrombotic versus thrombolytic era risk stratification of patients with acute myocardial infarction. Am J Cardiol 76:827–829

    Article  CAS  PubMed  Google Scholar 

  • Naidoo DP (2002) The link between microalbuminuria, endothelial dysfunction and cardiovascular disease in diabetes. Cardiovasc J S Afr 13:194–199

    CAS  PubMed  Google Scholar 

  • Nauta ST, Deckers JW, Akkerhuis KM, van Domburg RT (2012) Short- and long-term mortality after myocardial infarction in patients with and without diabetes: changes from 1985 to 2008. Diabetes Care 35:2043–2047

    Article  PubMed  PubMed Central  Google Scholar 

  • Niccoli G, Burzotta F, Galiuto L, Crea F (2009 Jul 21) Myocardial no-reflow in humans. J Am Coll Cardiol 54:281–292

    Article  PubMed  Google Scholar 

  • Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendíc S, Rydén L et al (2002) Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 359:2140–2144

    Article  CAS  PubMed  Google Scholar 

  • Norhammar A, Mellbin L, Cosentino F (2017) Diabetes: prevalence, prognosis and management of a potent cardiovascular risk factor. Eur J Prev Cardiol 24:52–60

    Article  PubMed  Google Scholar 

  • Odegaard AO, Jacobs DR Jr, Sanchez OA, Goff DC Jr, Reiner AP, Gross MD (2016) Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes. Cardiovasc Diabetol 15:51

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Orlander PR, Goff DC, Morrissey M, Ramsey DJ, Wear ML, Labarthe DR et al (1994) The relation of diabetes to the severity of acute myocardial infarction and post-myocardial infarction survival in Mexican-Americans and non-Hispanic whites: the Corpus Christi Heart Project. Diabetes 43:897–902

    Article  CAS  PubMed  Google Scholar 

  • Ovbiagele B, Markovic D, Fonarow GC (2011) Recent US patterns and predictors of prevalent diabetes among acute myocardial infarction patients. Cardiol Res Pract 2011:145615

    Article  PubMed  PubMed Central  Google Scholar 

  • Pfeffer MA, Claggett B, Diaz R, Dickstein K, Gerstein HC, Køber LV et al (2015) Lixisenatide in patients with type 2 diabetes and acute coronary syndrome. N Engl J Med 373:2247–2257

    Article  CAS  PubMed  Google Scholar 

  • Pinto DS, Skolnick AH, Kirtane AJ, Murphy SA, Barron HV, Giugliano RP et al (2005) TIMI Study Group. U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 46:178–180

    Article  CAS  PubMed  Google Scholar 

  • Pinto DS, Kirtane AJ, Pride YB, Murphy SA, Sabatine MS, Cannon CP, CLARITY-TIMI 28 Investigators et al (2008) Association of blood glucose with angiographic and clinical outcomes among patients with ST-segment elevation myocardial infarction (from the CLARITY-TIMI-28 study). Am J Cardiol 101:303–307

    Article  CAS  PubMed  Google Scholar 

  • Radke PW, Schunkert H (2010) Diabetics with acute coronary syndrome: advances, challenges, and uncertainties. Eur Heart J 31:2971–2973

    Article  PubMed  Google Scholar 

  • Rana OA, Byrne CD, Greaves K (2014) Intensive glucose control and hypoglycaemia: a new cardiovascular risk factor? Heart 100:21–27

    Article  PubMed  Google Scholar 

  • Rapsomaniki E, Thuresson M, Yang E, Blin P, Hunt P, Chung SC et al (2016) Using big data from health records from four countries to evaluate chronic disease outcomes: a study in 114 364 survivors of myocardial infarction. Eur Heart J Qual Care Clin Outcomes 2:172–183

    Article  PubMed  PubMed Central  Google Scholar 

  • Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, ODYSSEY OUTCOMES Committees and Investigators et al (2019) Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. Lancet Diabetes Endocrinol 7:618–628

    Article  CAS  PubMed  Google Scholar 

  • Rousan TA, Pappy RM, Chen AY, Roe MT, Saucedo JF (2014) Impact of diabetes mellitus on clinical characteristics, management, and in-hospital outcomes in patients with acute myocardial infarction (from the NCDR). Am J Cardiol 114:1136–1144

    Article  PubMed  Google Scholar 

  • Sabatine MS, Leiter LA, Wiviott SD, Giugliano RP, Deedwania P, De Ferrari GM et al (2017) Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial. Lancet Diabetes Endocrinol 5:941–950

    Article  CAS  PubMed  Google Scholar 

  • Savage MP, Krolewski AS, Kenien GG, Lebeis MP, Christlieb AR, Lewis SM (1988) Acute myocardial infarction in diabetes mellitus and significance of congestive heart failure as a prognostic factor. Am J Cardiol 62:665–669

    Article  CAS  PubMed  Google Scholar 

  • Soler NG, Pentecost BL, Bennett MA, FitzGerald MG, Lamb P, Malins JM (1974) Coronary care for myocardial infarction in diabetics. Lancet 1:475–477

    Article  CAS  PubMed  Google Scholar 

  • Stehouwer CD, Nauta JJ, Zeldenrust GC, Hackeng WH, Donker AJ, den Ottolander GJ (1992) Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non–insulin-dependent diabetes mellitus. Lancet 340:319–323

    Article  CAS  PubMed  Google Scholar 

  • Stranders I, Diamant M, van Gelder RE, Spruijt HJ, Twisk JW, Heine RJ et al (2004) Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 164:982–988

    Article  PubMed  Google Scholar 

  • Suleiman M, Hammerman H, Boulos M, Kapeliovich MR, Suleiman A, Agmon Y et al (2005) Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation 111:754–760

    Article  CAS  PubMed  Google Scholar 

  • Svensson AM, McGuire DK, Abrahamsson P, Dellborg M (2005) Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J 26:1255–1261

    Article  PubMed  Google Scholar 

  • Teraguchi I, Imanishi T, Ozaki Y, Tanimoto T, Kitabata H, Ino Y et al (2012) Impact of stress hyperglycemia on myocardial salvage following successfully recanalized primary acute myocardial infarction. Circ J 76:2690–2696

    Article  PubMed  Google Scholar 

  • Timmer JR, Ottervanger JP, de Boer MJ, Dambrink JH, Hoorntje JC, Gosselink AT (2005) Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. J Am Coll Cardiol 45:999–1002

    Article  CAS  PubMed  Google Scholar 

  • Timmers L, Henriques JP, de Kleijn DP, Devries JH, Kemperman H, Steendijk P et al (2009) Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury. J Am Coll Cardiol 53:501–510

    Article  CAS  PubMed  Google Scholar 

  • Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE (2002) Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 87:978–982

    Article  CAS  PubMed  Google Scholar 

  • Undas A, Wiek I, Stêpien E, Zmudka K, Tracz W (2008) Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome. Diabetes Care 31:1590–1595

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL, ICONS Investigators (2002) Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 40:1748–1754

    Article  CAS  PubMed  Google Scholar 

  • White WB, Cannon CP, Heller SR, Nissen SE, Bergenstal RM, Bakris GL et al (2013) Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med 369:1327–1335

    Article  CAS  PubMed  Google Scholar 

  • White WB, Heller SR, Cannon CP, Howitt H, Khunti K, Bergenstal RM, EXAMINE Investigators et al (2018) Alogliptin in patients with type 2 diabetes receiving metformin and sulfonylurea therapies in the EXAMINE trial. Am J Med 131:813.e5–819.e5

    Article  CAS  Google Scholar 

  • Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053

    Article  PubMed  Google Scholar 

  • Wiviott SD, Braunwald E, Angiolillo DJ, Meisel S, Dalby AJ, Verheugt FW et al (2008) Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38. Circulation 118:1626–1636

    Article  CAS  PubMed  Google Scholar 

  • Woo JS, Kim W, Ha SJ, Kim JB, Kim SJ, Kim WS et al (2013) Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study. Arterioscler Thromb Vasc Biol 33:2252–2260

    Article  CAS  PubMed  Google Scholar 

  • Woodfield SL, Lundergan CF, Reiner JS, Greenhouse SW, Thompson MA, Rohrbeck SC et al (1996) Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. J Am Coll Cardiol 28:1661–1669

    Article  CAS  PubMed  Google Scholar 

  • Worthley M, Holmes AS, Willoughby SR, Kucia AM, Heresztyn T, Stewart S et al (2007) The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes. Mediation by superoxide production, resolution with intensive insulin administration. J Am Coll Cardiol 49:304–310

    Article  CAS  PubMed  Google Scholar 

  • Yeh RW, Secemsky EA, Kereiakes DJ, Normand SL, Gershlick AH, Cohen DJ, DAPT Study Investigators et al (2016) Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention. JAMA 315:1735–1749

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yudkin JS, Oswald GA (1988) Determinants of hospital admission and case fatality in diabetic patients with myocardial infarction. Diabetes Care 11:351–358

    Article  CAS  PubMed  Google Scholar 

  • Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, INTERHEART Study Investigators et al (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364:937–952

    Article  PubMed  Google Scholar 

  • Zeller M, Steg PG, Ravisy J, Laurent Y, Janin-Manificat L, L’Huillier I et al (2005) Observatoire des Infarctus de Côte-d’Or Survey Working Group. Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction. Arch Intern Med 165:1192–1198

    Article  PubMed  Google Scholar 

  • Zhao S, Murugiah K, Li N, Li X, Xu ZH, Li J et al (2017) Admission glucose and in-hospital mortality after acute myocardial infarction in patients with or without diabetes: a cross-sectional study. Chin Med J 130:767–775

    Article  PubMed  PubMed Central  Google Scholar 

  • Zuanetti G, Latini R, Maggioni AP, Santoro L, Franzosi MG; for the GISSI-2 Investigators (1993) Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study. J Am Coll Cardiol 22:1788–1794

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centro Cardiologico Monzino IRCCS, Milan, Italy

    Valentina Milazzo, Nicola Cosentino, Stefano Genovese, Jeness Campodonico, Mario Mazza, Monica De Metrio & Giancarlo Marenzi

Authors
  1. Valentina Milazzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nicola Cosentino
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stefano Genovese
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jeness Campodonico
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mario Mazza
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Monica De Metrio
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Giancarlo Marenzi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giancarlo Marenzi .

Editor information

Editors and Affiliations

  1. Department of Clinical Science and Education, Karolinska Institutet, Stockholm, Sweden, Department of Emergency Care and Internal Medicine, Uppsala University Hospital, Uppsala University, Uppsala, Sweden

    Md. Shahidul Islam

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Milazzo, V. et al. (2020). Diabetes Mellitus and Acute Myocardial Infarction: Impact on Short and Long-Term Mortality. In: Islam, M.S. (eds) Diabetes: from Research to Clinical Practice. Advances in Experimental Medicine and Biology(), vol 1307. Springer, Cham. https://doi.org/10.1007/5584_2020_481

Download citation

  • DOI: https://doi.org/10.1007/5584_2020_481

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-51088-6

  • Online ISBN: 978-3-030-51089-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation